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The intestinal epithelium is characterized by a repetitive ar-
chitecture made of crypt–villus units and is seen as a pow-
erful experimental model to study adult stem cells in health 
and diseases (Clevers, 2013; Barker, 2014). Each villus is cov-
ered by a single layer of postmitotic cells and is surrounded 
at its base by multiple epithelial invaginations, referred to as 
crypts of Lieberkühn. Each crypt–villus unit is composed of 
six differentiated epithelial cell types. These are lysozyme and 
defensin-secreting Paneth cells located at the bottom of the 
crypts, absorptive enterocytes, Goblet and enteroendocrine 
cells that secrete mucus or hormones, microfold (M) cells that 
play essential roles in mucosal immunity, and rare post-mitotic 
Tuft cells (also referred to as Brush cells) whose biological 
functions remain to be defined (Clevers, 2013).
Tuft cells originate from poorly characterized tuft cell 
progenitors, are enriched in acetylated α-tubulin, and show 
characteristic microtubule and actin bundles located at the 
cell apex exposed to the luminal environment (Gerbe et al., 
2011, 2012). They are distinct from intestinal secretory cells, 
as transcription factors such as Neurog3, Sox9, and Spdef are 
dispensable for their generation (Gerbe et al., 2011; Bjerknes 
et al., 2012). Tuft cells specifically express Doublecortin-like 
kinase 1 (Dclk1; also referred to as Dcamkl-1) as well as the 
transcription factor Gfi1B (Bjerknes et al., 2012; Gerbe et al., 
2012). Sox9 is also expressed in Tuft cells, but is not seen as 
a specific tuft cell marker because of its strong expression in 
Paneth cells (Bastide et al., 2007; Mori-Akiyama et al., 2007). 
Identifying molecular determinants for the specification and 
differentiation of Tuft cells is therefore critical to shed more 
light on their poorly understood biological functions.
The intense self-renewal kinetics of the intestinal epithe-
lium relies on crypt base columnar (CBC) stem cells located 
at the bottom of intestinal crypts together with Paneth cells. 
Cycling CBC cells express the Wnt target gene Leucine-rich 
repeat containing G protein-coupled receptor 5 (Lgr5; Barker 
et al., 2007). A second pool of quiescent stem cells has also 
been described in the intestine. Indeed, DNA label–retaining 
cells (LRCs), also referred to as +4 stem cells, are located 
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above Paneth cells and express various markers such as Bmi1, 
Hopx, mTERT, and Lrig1 (Potten et al., 1978; Sangiorgi and 
Capecchi, 2008; Montgomery et al., 2011; Takeda et al., 2011; 
Powell et al., 2012). Importantly, a high level of plasticity oc-
curs between Lgr5+ and LRC stem cells as Hopx-expressing 
+4 cells can generate Lgr5+ cells, whereas the latter can also 
express +4 stem cell markers (Takeda et al., 2011; Muñoz et 
al., 2012). Similarly, Lgr5+ cells mark a heterogeneous popula-
tion as Lgr5high stem cells are mitotically active, whereas other 
Lgr5low progenitors exit the cell cycle (Basak et al., 2014).
Wnt signaling fuels the stem cell compartment and also 
critically controls tumor development in the intestine by pro-
moting crypt proliferation through transcriptional activation 
of Tcf target genes (Clevers and Nusse, 2012). Although it is 
not totally clear how cancer stem cells are controlled by Wnt 
signaling, it has nevertheless been demonstrated that Lgr5+ 
stem cells critically drive tumor initiation (van de Wetering 
et al., 2002; Barker et al., 2009; Schepers et al., 2012; Clev-
ers, 2013). The tuft cell marker Dclk1 also appears to distin-
guish cancer versus normal stem cells (Nakanishi et al., 2013). 
Dclk1+ cells have been demonstrated to sustain tumor growth 
in the intestine, but it is currently unclear how Dclk1 expres-
sion is regulated (Westphalen et al., 2014). A better charac-
terization of proteins acting downstream of the oncogenic 
Wnt signaling pathway and required for the maintenance of 
intestinal cancer stem cells is therefore required.
The intestine, as a proliferative and self-renewing organ, 
is highly sensitive to DNA-damaging agents, but regenerates 
when subjected to high doses of radiation. Indeed, intestinal 
stem cells that escaped from massive p53-mediated apoptosis 
undergo cell proliferation and repopulate the intestine within 
a few days, a process that critically relies on Wnt signaling 
(Withers and Elkind, 1970; Merritt et al., 1994; Ashton et 
al., 2010; Cordero and Sansom, 2012). The mitotically active 
Lgr5+ cells, although dispensable for intestinal homeostasis, 
are critical for intestinal regeneration upon damage. Nota-
bly, upon caloric restriction or expression of the Wnt agonist 
R-spondin1, the increased number of Lgr5+ cells promotes 
protection against intestinal damage (Bhanja et al., 2009; Tian 
et al., 2011; Yilmaz et al., 2012; Metcalfe et al., 2013; Zhou et 
al., 2013). Similarly, a population of quiescent LRCs, defined 
as Paneth cell precursors that express Paneth and +4 markers, 
can revert back into proliferating Lgr5+ cells upon radiation 
(Buczacki et al., 2013). Another study also defined an intes-
tinal Dclk1+ quiescent cell population required for regenera-
tion as the genetic ablation of Dclk1 led to defects in recovery 
after intestinal injury (Westphalen et al., 2014). Moreover, the 
transcription factor Sox9 is also critical for epithelial regen-
eration after high-dose irradiation highlighted (Roche et al., 
2015). Still, the molecular mechanism governing stem cell 
plasticity during radiation-induced intestinal regeneration re-
mains poorly characterized.
Elp3 is the catalytic subunit of Elongator (Elp1-Elp6), a 
protein complex initially identified as a component of a hy-
perphosphorylated RNA polymerase II holoenzyme isolated 
from budding yeast chromatin. Elp3 sequence harbors mo-
tifs found in the GNAT family of histone acetyltransferases 
(HATs; Otero et al., 1999; Wittschieben et al., 1999; Kim et 
al., 2002) and a radical S-adenosylmethionine (SAM) domain 
at the N-terminal region that includes a FeS cluster critical 
for Elongator integrity (Greenwood et al., 2009). Elongator 
promotes transcriptional elongation in the nucleus through 
histone H3 acetylation but also, as a cytoplasmic complex, in 
translational efficiency by adding 5-methoxycarbonylmethyl 
(mcm5) and 5-carbamoylmethyl (ncm5) groups on uridines at 
the wobble position of some tRNAs (Kristjuhan et al., 2002; 
Winkler et al., 2002; Huang et al., 2005; Close et al., 2006; 
Esberg et al., 2006; Bauer et al., 2012; Lin et al., 2013). Elon-
gator promotes cell migration in a variety of primary and 
transformed cells (Close et al., 2006, 2012; Creppe et al., 2009; 
Lee et al., 2009). However, it is unclear whether Elongator is 
involved in tumor development in vivo.
We show here that Elp3 expression is induced by Wnt 
signaling, promotes Tuft cell differentiation, and is essential 
for Wnt-driven tumor development in the intestine, as well as 
for radiation-induced intestinal regeneration. Mechanistically, 
our data support a model in which Lgr5+ cells rely on Elp3 to 
initiate tumor development upon constitutive Wnt signaling 
at least through the maintenance of a pool of Lgr5+/Dclk1+/
Sox9+ cells. We show that Elp3 regulates Sox9 protein levels 
through tRNA modification. Therefore, we define Elp3 as 
a downstream effector of Wnt signaling that controls Sox9 
translation and maintains a pool of Lgr5+/Dclk1+/Sox9+ cells 
to drive tumor initiation in the intestine.
RES ULTS
ELP1 and ELP3 are Wnt target genes
Elongator-deficient melanoma cells fail to form colonies in 
soft agar (Close et al., 2012). The anchorage-independent 
growth of two colon cancer–derived cell lines, HCT116 and 
HT29, is also strongly impaired after Elp3 depletion (unpub-
lished data). Both HCT116 and HT29 cells harbor enhanced 
Wnt signaling as a result of β-catenin or APC mutations, re-
spectively (Morin et al., 1997; Wang et al., 2003), suggest-
ing a crucial role of Elongator in Wnt-driven tumorigenesis. 
As β-catenin critically drives colony formation in soft agar 
(Verma et al., 2003), we next investigated whether Elongator 
is functionally connected to Wnt- and β-catenin–dependent 
signaling pathways. β-catenin nuclear levels, as well as ex-
pression of described Wnt target genes, remained unchanged 
upon ELP3 deficiency in HT29 cells, indicating that Elonga-
tor is dispensable for Wnt signaling activation (unpublished 
data). We then impaired the Wnt pathway by generating 
β-catenin–depleted HT29 cells and noticed that ELP1 and 
ELP3 mRNA levels decreased upon β-catenin deficiency, 
similarly to other Wnt target genes, such as Lgr5, Axin 2, Cy-
clin D1, and c-Myc (Fig. 1 A). Conversely, Wnt activation in 
RKO cells, which have low intrinsic Wnt signaling,increased 
Elp3 protein levels (Fig. 1 B), suggesting that ELP3 expression 
is β-catenin-dependent in colon cancer–derived cells. The 
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Elp3 promoter harbors multiple TCF4-binding sites, and we 
detected a specific recruitment of TCF4 on two sites located 
3,400 and 3,200 bp upstream from the transcription start site 
by ChIP assays (Fig. 1 C). To investigate whether this finding 
is also relevant in vivo, we assessed Elp1 and Elp3 mRNA 
levels in control versus Apc+/min mice, which spontaneously 
develop adenocarcinomas as a result of constitutive Wnt sig-
naling (Su et al., 1992). Similarly to c-Myc, Elp1 and Elp3 
mRNAs dramatically increased over time in intestinal epi-
thelial cells (IECs) from Apc+/min, but not from control mice 
(Fig. 1 D). ELP3 expression was also higher in human intes-
tinal carcinomas than in normal adjacent tissues, similar to 
c-MYC (Fig. 1 E). Consistently, in human samples of colon 
cancer, ELP3 protein expression was enriched in parts enclos-
ing adenomas and carcinomas compared with normal intesti-
nal epithelia, as shown by anti-ELP3 immunohistochemistry 
analyses (Fig. 1 F). Collectively, our data indicate that Elp3 
expression is Wnt and β-catenin dependent in the intestine 
and is enhanced upon constitutive Wnt signaling.
Elp3 promotes Tuft cell differentiation in the intestine
Having defined Elp3 as a Wnt target, we next assessed its role 
in intestinal homeostasis. We first generated a genetically en-
gineered mouse model in which the exon 2 of the Elp3 gene 
was flanked with LoxP sites to create the conditional knock-
out (KO) allele (referred hereafter to as Elp3Control). Deletion 
of exon 2 upon Cre expression results in Elp3 loss of function 
by generating a frameshift to all downstream exons (Fig. 2 A). 
The constitutive knockout alleles generated by crossing our 
Elp3Control strain with the Villin-Cre mouse (referred hereafter 
to as Elp3ΔIEC) was indeed identified in IECs through PCR 
analysis (Fig. 2 B). As a result, Elp3 expression was severely 
decreased in IECs of Elp3ΔIEC mice (Fig. 2, C and D). The 
absence of Elp3 in IEC did not impact on the overall gain 
of weight of mice over lifetime (Fig. 2 E). Moreover, no ob-
vious defect in the intestinal architecture was observed (un-
published data). The number of cycling cells in the transient 
amplifying compartment, as well as cell death at the top of 
intestinal villi were intact upon Elp3 deficiency, as judged 
by Ki67 and cleaved Caspase 3 staining performed in 4-mo-
old control or Elp3ΔIEC mice (unpublished data). Moreover, 
mRNA levels of markers of CBC cells Olfm4, Lgr5, and 
Achaete Scute-like 2 (Ascl2; van der Flier et al., 2009) re-
mained unchanged (unpublished data). Quiescent, Paneth, 
and Goblet cell markers were also properly expressed upon 
Elp3 deficiency, as were Atonal homologue 1 (Atoh1) and 
hairy/enhancer of split 1 (Hes1), which control the balance 
between secretory or absorptive lineages (Jensen et al., 2000; 
Yang et al., 2001; and unpublished data). Of note, mRNA 
levels of Chromogranin A, an enteroendocrine cell marker, 
slightly decreased upon Elp3 deficiency (unpublished data). 
Surprisingly, all tested markers of Tuft cell, namely Dclk1, 
Cox1, and Gfi1B (Gerbe et al., 2011, 2012; Bjerknes et al., 
2012), were decreased in their mRNA levels upon Elp3 de-
ficiency (Fig. 2 F). As a consequence, intestinal Dclk1 pro-
tein levels were strikingly reduced (Fig.  2 G). The number 
of Dclk1+ cells actually decreased in Elp3-deficient intestinal 
crypts, as judged by IHC analyses (Fig. 2 H), suggesting that 
Elp3 is critical for Tuft cell differentiation. IF analyses fur-
ther showed that the number of Tuft cells, defined as Dclk1+/
acetylated α-tubulin+ cells (Saqui-Salces et al., 2011), was sig-
nificantly lower upon Elp3 deficiency in intestinal epithelia 
(Fig. 2 I). Thus, Elp3 specifically promotes the differentiation 
of Tuft cells in healthy crypts but does not affect the overall 
homeostasis of the intestine.
Wnt-driven tumor initiation requires Elp3
Because Elp3 is required for colony formation in colon can-
cer cells showing constitutive Wnt signaling, and because Wnt 
signaling promotes Elp3 expression in the intestine, we next 
explored the putative role of Elp3 in Wnt-driven intestinal 
tumor development by crossing Elp3Control or Elp3ΔIEC mice 
with the Apc+/min strain. As expected, Elp3 expression was 
severely impaired in intestinal crypts of the resulting mouse 
model (Apc+/min Elp3ΔIEC), as confirmed by real-time PCR 
analysis (Fig.  3  A). Strikingly, Elp3 deficiency in Apc+/min 
mice dramatically extended their life span due to a severe 
decrease in tumor number in proximal, middle, and distal in-
testines (Fig. 3, B–E). Splenomegaly, a typical feature of Apc+/min 
mice (Lane et al., 2010), did not occur upon Elp3 deficiency, 
as spleen weight of Apc+/min Elp3ΔIEC mice were almost iden-
tical to those seen in Elp3Control or in Elp3ΔIEC mice (Fig. 3, 
F and G). Moreover, decreased hematocrit levels, another 
feature of Apc+/min mice, was not observed upon Elp3 de-
ficiency (Fig. 3 H). Additionally, Elp3 deletion strongly im-
paired spheroid structure formation from ex vivo culture of 
Apc-mutated intestinal crypts (Fig. 3 I). Together, these data 
demonstrate that Elp3 promotes Wnt-driven tumor initi-
ation in the intestine.
Lgr5+ cells require Elp3 to promote Wnt-dependent tumor 
initiation in the intestine
Given the critical role of Lgr5+ cells in tumor initiation (Barker 
et al., 2009; Schepers et al., 2012), we next wondered whether 
the genetic inactivation of Elp3 in Lgr5+ cells would also im-
pact on Wnt-driven tumor initiation. To address this issue, we 
first crossed the stem cell–specific Lgr5-EGFP-IRES-creERT2 
knock-in mouse with our Elp3lox/lox strain and subsequently 
deleted Elp3 in the resulting mice through tamoxifen admin-
istration (referred to as Lgr5-EGFP-Elp3ΔCBC). Tamoxifen was 
also administered in the Lgr5-EGFP-IRES-creERT2 strain as 
control (referred to as Lgr5-EGFP-Elp3Control). Notably, Elp3 
expression was enriched in cycling Lgr5+ (EGFP+) cells, 
which provides an additional demonstration for Wnt signal-
ing acting as a driver of Elp3 expression (unpublished data). 
Impaired Elp3 expression was specifically observed in sorted 
EGFP+ cells upon tamoxifen injection (unpublished data). Im-
portantly, Elp3 deficiency did not impact on the number of 
Lgr5+ cells (unpublished data). Therefore, Elp3 is dispensable 
for the maintenance of Lgr5+ stem cells in healthy crypts.
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We next crossed the Apclox/lox strain with the Lgr5-EG-
FP-IRES-creERT2 knock-in mouse and with our Elp3lox/lox 
strain. Both Apc and Elp3 were simultaneously inactivated 
in Lgr5+ cells of the resulting mouse through tamoxifen ad-
ministration (referred to as ApcΔCBC Elp3ΔCBC). Tamoxifen 
was also administered in mice resulting from the breeding 
of Apclox/lox mice with the Lgr5-EGFP-IRES-creERT2 strain 
(referred to as ApcΔCBC). As expected, numerous hyperpla-
sias that resulted from constitutive Wnt signaling in Lgr5+ 
cells were observed 15 d after tamoxifen administration in 
Figure 1. Wnt signaling induces ELP3 ex-
pression. (A) HT29 cells were infected with the 
indicated lentiviral constructs and protein ex-
tracts from the resulting cells were subjected 
to Western blot (WB) analyses. α-tubulin and 
Histone H3 are used as controls for the cy-
toplasmic and nuclear fractions, respectively 
(top). At the bottom, control (shRNA CTRL) or 
β-catenin–depleted HT29 cells (shRNA β-Cat-
enin #1 or #2) were subjected to quantitative 
real-time PCR analysis to monitor Wnt target 
genes, as well as ELP1 and ELP3 mRNA levels. 
Data from three independent experiments 
(mean values ± SD; Student’s t test; *, P < 0.05; 
**, P < 0.01; ***, P < 0.001) are shown. (B) An-
ti-ELP3, –β-Catenin, and –α-tubulin WB anal-
yses with whole-cell lysates from RKO cells 
treated or not with Wnt 3a (100 ng/ml) for the 
indicated periods of time were performed. 
(C) TCF4-binding sites were identified on the 
Elp3 promoter (positions relative to the tran-
scription start site are indicated). ChIP assays 
were conducted using extracts from HT29 cells 
and an anti-TCF4 or a nonrelevant (CTRL) anti-
body. Associated DNA was analyzed by quan-
titative real-time PCR using primers spanning 
the indicated TCF4-binding sites. Signals are 
expressed as IP/Input ratio for each primer 
pair normalized to control. Data from three 
experiments performed in triplicate are shown 
(mean values ± SD; Student’s t test; *, P < 0.05; 
**, P < 0.01). (D) Total mRNAs from IEC of con-
trol or Apc+/min mice were subjected to quan-
titative real-time PCR analysis to assess Elp3 
and Elp1 expression. Abundance of Villin tran-
scripts was used as control. Error bars denote 
SD. (**, P < 0.01; ***, P < 0.001; Mann-Whitney 
test; n ≥ 5). (E) Total mRNAs from nine intes-
tinal carcinomas or from adjacent normal tis-
sues were subjected to quantitative real-time 
PCR to assess ELP3, MYC, and LGR5 levels. The 
figure shows the mRNA expression levels of all 
transcripts in adenomas relative to their levels 
in normal adjacent tissues after normalization 
with β-2 microglobulin. (n = 9; **, P < 0.01; 
Wilcoxon-matched paired test). (F) Anti-ELP3 
immunohistochemistry (IHC) was conducted 
in human cases of intestinal malignancies, 
as well as in normal intestinal epithelia. Rep-
resentative images are shown. The average 
Elp3-specific signal has been quantified and 
plotted (mean values ± SD; Student’s t test; 
*, P < 0.05; ***, P < 0.001).
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Figure 2. Elp3 promotes Tuft cell differentiation. (A) LoxP sites flanking exon 2 of the Elp3 gene were inserted. Deletion of exon 2 upon Cre expression 
results in loss of function of Elp3 by generating a frameshift to all downstream exons (red boxes). Primers used for detection of the wild-type or mutated 
alleles are depicted by arrows. (B) Genomic DNA was extracted from IECs of Elp3lox/lox (Elp3Control) or Elp3lox/lox VillinCre/+ (Elp3ΔIEC) mice and subjected to PCR 
analysis using primers 1 and 2 to amplify the wild-type or recombinant allele (1,341- or 172-bp fragments, respectively). (C) mRNAs from Elp3Control and 
Elp3ΔIEC mice were subjected to quantitative real-time PCR analysis to assess Elp3 mRNA levels (mean values ± SD; Student’s t test; ***, P < 0.001). 
(D) Anti-Elp3 IHC analyses were performed with intestinal crypts from 120-d-old Elp3Control and Elp3ΔIEC mice. (E) The weight of five male Elp3Control and 
Elp3ΔIEC mice (8–55 wk old) was quantified and plotted. Weights were normalized at 8 wk of age for each genotype. (F) Intestinal epithelial cells (IECs) were 
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ApcΔCBC mice, as demonstrated by H&E and Ki67 IHC 
analyses (Fig.  4, A and B). Those areas of hyperplasia also 
showed elevated numbers of Dclk1+ cells (Fig.  4  C). Elp3 
deficiency in Lgr5+ and Apc-deleted cells did not impact the 
total number of Lgr5+ cells, but severely impaired tumor ini-
tiation, as judged by decreased numbers of hyperplastic foci 
(not depicted and Fig. 4, A and B, respectively). The number 
of Dclk1+ cells was also decreased in the rare Elp3-deficient 
hyperplastic foci (Fig. 4 C). Importantly, Dclk1+ cells found 
in these hyperplastic foci were largely negative for acetyl-
ated-α-tubulin staining, as compared with adjacent crypts, 
which supports the notion that they are not Tuft cells (un-
published data). Therefore, Elp3 expression in Lgr5+ cells is 
required for Wnt-dependent intestinal tumor initiation. Intes-
tinal crypts extracted from ApcΔCBC Elp3ΔCBC mice also failed 
to efficiently generate spheroid structures ex vivo (Fig. 4 D). 
To further demonstrate that Elp3 expression is required for 
the self-renewal capacity of Lgr5+ cancer stem cells, FACS-
sorted Lgr5+ cells from both ApcΔCBC and ApcΔCBC Elp3ΔCBC 
mice were subjected to an in vitro limiting dilution assay. Elp3 
ablation strongly affected the Lgr5+ cells cancer stem cell po-
tential (Fig. 4 E). Therefore, the cancer stem cell potential of 
Lgr5+ cells relies on Elp3 in the intestine.
Elp3 maintains the pool of Dclk1+ cells in the intestine
We next explored the mechanisms underlying the role of Elp3 
in Wnt-driven intestinal tumor initiation. Nuclear β-catenin 
protein levels, as well as mRNA levels of Wnt target genes, 
such as c-Myc, EphB2, and Tcf-1, were unchanged in 4-mo-
old Apc+/min Elp3ΔIEC mice (unpublished data) as compared 
with Apc+/min Elp3Control mice. Moreover, crypt cell prolifer-
ation and cell apoptosis at the top of the villi remained un-
changed upon Elp3 deficiency in Apc+/min mice (unpublished 
data), as were the number of goblet cells, apical enterocytes, 
Paneth, and enteroendocrine cells (unpublished data). Of 
note, Atoh1 and Hes1 mRNA levels were also unchanged in 
Elp3-deficient Apc+/min mice, as were several markers of cell 
differentiation, namely Krt20, Anpep, and Prss7 (unpublished 
data). In agreement with a dispensable role of Elp3 in the 
maintenance of Lgr5+ cells in ApcΔCBC mice, Lgr5, but also 
Ascl2, mRNA levels did not change upon Elp3 deficiency 
in intestinal tumors of Apc+/min mice (Fig. 5 A). Interestingly, 
in line with the fact that Dclk1+ cells in tumors are distinct 
from tuft cells, both Dclk1 and Gfi1B, but not COX1, were 
decreased at the mRNA level upon Elp3 deficiency in the 
Apc+/min tumors (Fig. 5 B). Dclk1, whose protein levels were 
higher in cystic lesions than in adenocarcinomas (Fig. 5 C), 
was also less expressed in IECs extracted from Apc+/min 
Elp3ΔIEC mice, as shown by IHC and WB analyses (Fig.  5, 
D and E). Consistently, the number of Dclk1+ cells in both 
tumors and adjacent regions significantly decreased in the 
intestine of Apc+/min Elp3ΔIEC mice (Fig.  5  F). Importantly, 
although the number of Tuft cells (Dclk1+ and acetylated 
α-tubulin+ cells) slightly decreased, the number of Dclk1+/
acetylated α-tubulin− cells dramatically decreased in Apc+/min 
Elp3ΔIEC mice (Fig. 5 G). Importantly, the depletion of Dclk1 
in ex vivo organoid cultures with intestinal crypts extracted 
from ApcΔCBC mice did not impact on Elp3 expression, but 
interfered with the generation of spheroid structures, similar 
to Elp3 deficiency (Fig. 5 H). Therefore, Elp3 promotes Wnt-
driven tumor initiation in the intestine, at least by maintain-
ing the pool of Dclk1+ cells.
Elp3 promotes Sox9 expression through tRNA modifications
Constitutive Wnt signaling induces significant changes in 
gene and protein expression to promote tumor develop-
ment (Sansom et al., 2007). Sox9 is required downstream 
of Wnt/β-catenin signaling for the long term self-renewal 
of oncogene-expressing cells in a genetic mouse model of 
basal cell carcinoma (Larsimont et al., 2015). Moreover, Sox9 
is expressed in intestinal crypts as a Wnt target gene and is 
consequently overexpressed upon constitutive Wnt signal-
ing (Blache et al., 2004). Therefore, we hypothesized that 
the blockage of Wnt-driven tumor development upon Elp3 
deficiency may be due, at least in part, to a defective Sox9 
expression. As expected, Sox9 levels were robustly increased 
in Apc+/min intestinal crypts as a result of constitutive Wnt 
signaling (Fig. 6 A). Importantly, its expression was severely 
decreased in Apc+/min Elp3ΔIEC mice to reach similar levels 
as in normal intestinal crypts (Fig. 6 A). Consistently, Sox9 
protein levels dramatically decreased in Apc+/min Elp3ΔIEC ver-
sus Apc+/min Elp3Control mice (Fig.  6  B). Igfbp4, a stem cell 
marker whose expression is Sox9-dependent in the intestine 
(Merlos-Suárez et al., 2011; Shi et al., 2013), was consequently 
less expressed upon Elp3 deficiency in intestinal crypts from 
Apc+/min mice (Fig. 6 C). Thus, Elp3 is critical for the expres-
sion of Sox9 seen upon Apc loss. This conclusion was further 
supported by the fact that although Wnt 3a increased ELP3 
and SOX9 expression, both at the mRNA and protein levels 
through β-catenin stabilization in control RKO cells, it failed 
to induce SOX9 protein expression upon ELP3 deficiency 
(Fig. 6 D and not depicted). Importantly, the number of ex 
isolated from 120-d-old Elp3Control and Elp3ΔIEC mice, and the resulting total mRNAs were subjected to quantitative real-time PCR analysis to assess mRNA 
levels of the indicated candidates (mean values ± SD; Student’s t test; ***, P < 0.001; n = 6). (G) Anti-Dclk1 and α-tubulin (loading control) WBs were per-
formed on cell extracts from IECs of Elp3Control and Elp3ΔIEC 120-d-old mice. (H; left) Anti-Dclk1 IHC in intestinal crypts from the indicated genotypes. (right) 
Quantification of Dclk1-positive cells per crypt showing significant decrease of Dclk1 upon Elp3 deficiency in the intestine (mean values ± SD; Student’s t 
test; **, P < 0.01; n = 4). (I) Anti-Dclk1 and acetylated α-tubulin immunofluorescence (IF) analyses were performed to visualize Tuft cells in Elp3Control and 
Elp3ΔIEC mice, as indicated. The graph represents the quantification of the Dclk1/acetylated-α-tubulin double-positive cells in both genotypes (mean values 
± SD; Student’s t test; ***, P < 0.001).
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Figure 3. Elp3 is required for tumor development in a mouse model of colon cancer. (A) IECs were isolated from Apc+/min Elp3Control and Apc+/min 
Elp3ΔIEC 120-d-old mice and the resulting total mRNAs were subjected to quantitative real-time PCR analysis to assess Elp3 mRNA levels (mean values ± SD; 
Student’s t test; ***, P < 0.001; n = 4). (B) A Kaplan–Meyer curve (P < 0.001; n ≥ 16) was established with the indicated genotypes. (C and D) The histograms 
show the total number of adenomas in the entire intestine (C) or in the indicated areas (D) of 120-d-old control (Apc+/min Elp3Control) and Elp3-deficient mice 
(Apc+/min Elp3ΔIEC; mean values ± SD; Student’s t test; ***, P < 0.001; n ≥ 11). (E) Representative pictures of jejunal section of 120-d-old Apc+/min Elp3Control and 
Apc+/min Elp3ΔIEC mice. H&E and K67 staining are also illustrated. (F) Representative pictures of the spleen from the indicated genotypes. (G) Quantification 
of the spleen weight of 120-d-old mice from the indicated genotypes (mean values ± SD; Student’s t test; ***, P < 0.001; n ≥ 7). (H) Hematocrit levels in the 
indicated genotypes of 3-mo-old mice (Elp3Control, n = 4; Apc+/min Elp3Control, n = 9; Elp3ΔIEC, n = 3) and Apc+/min Elp3ΔIEC (n = 9) was assessed and plotted (mean 
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vivo spheroid structures generated from ApcΔCBC mice simi-
larly decreased upon Sox9 or Elp3 depletion, suggesting that 
Elp3 promotes intestinal Wnt-driven tumor initiation at least 
by promoting Sox9 expression (Fig. 6 E).
Intriguingly, Sox9 mRNA levels remained unchanged 
upon Elp3 deficiency in the Apc+/min model, as shown by 
quantitative real-time PCR and in situ hybridization (Fig. 6 C 
and not depicted, respectively). Moreover, Sox9 transcription 
was properly induced upon Wnt 3a stimulation in RKO cells 
(unpublished data), suggesting that Elp3 regulates Sox9 ex-
pression at the posttranscriptional level. Of note, mRNA lev-
els of various proteins known to regulate the acetylation or 
sumoylation of Sox9 (Tip60, Ubc9, Pias1, Pias4, and Senp2, 
respectively; Hattori et al., 2006, 2008) were properly ex-
pressed upon Elp3 deficiency in Apc+/min mice (unpublished 
data), suggesting that Sox9 post-translational modifications 
known to interfere with its stability are not responsible for 
the decreased protein levels seen upon Elp3 deficiency. In 
yeast, Elp3 promotes translational efficiency through tRNA 
modification (Huang et al., 2005). To understand if Sox9 de-
crease upon Elp3 deficiency is due to translational defects, we 
expressed a Sox9 cDNA in wild-type and elp3-deleted fission 
yeast cells (Fig. 6 F). Strikingly, the absence of Elp3 impeded 
Sox9 expression, which was restored upon overexpression of 
the unmodified tRNAlysUUU, a critical target of Elongator. As 
Elp3 promotes the translation of AAA-enriched polypeptides 
in yeast (Bauer et al., 2012), we next generated a Sox9 expres-
sion construct in which all three AAA codons (K167, 242, and 
249) found in the Sox9 murin sequence were mutated into 
their cognate Elp3-insensitive AAG codons (Sox9ΔAAA). We 
then assessed Sox9ΔAAA expression in control versus Elp3 
mutant yeast strain. Interestingly, Sox9ΔAAA but not wild-
type Sox9 was properly expressed in yeast Elp3 mutant strain 
(Fig. 6 G). Therefore, Elp3-mediated tRNA modification is 
critical for Sox9 proper translation.
Elp3 expression is required to maintain a pool  
of Lgr5+/Dclk1+/Sox9+ cells in the intestine
To better understand how the Elp3-dependent translation 
of Sox9 expression impacts on the number of Dclk1+ cells, 
we assessed Elp3, Sox9 and Dclk1 levels in ex vivo organ-
oid cultures generated from ApcΔCBC mice and depleted for 
Elp3 or Sox9. As expected, Elp3 deficiency decreased both 
Dclk1 and Sox9 protein levels (Fig. 7 A). In agreement with 
our previous data, Sox9 mRNA levels did not decrease in 
Elp3-depleted organoids (unpublished data). Yet, both Dclk1 
and Gfi1B, but not Cox1, mRNA levels were decreased upon 
Elp3 depletion, supporting the notion that Elp3 controls the 
maintenance of a subpopulation of Dclk1+ cells which differ 
from Tuft cells upon constitutive Wnt activation (Fig. 7 A). 
Importantly, Sox9 depletion in ex vivo organoids also largely 
decreased Dclk1 mRNA and protein levels, suggesting that 
a pool of Dclk1+ cells relies on both Sox9 and Elp3 expres-
sion for its maintenance. Finally, Dclk1 depletion in Apc+/min 
ex vivo organoids, did not affect Sox9 or Elp3 mRNA and 
protein levels, but decreased the number of spheroid struc-
tures as seen for Sox9 or Elp3 depletion (Fig. 5 H), strength-
ening the notion that both Elp3 and Sox9 are required to 
maintain Dclk1+ cells.
Having established a link between Sox9 expression and 
Dclk1+ cells, we next explored whether a Dclk1+/Sox9+ cell 
population can be detected in Lgr5-expressing cells and if 
so, whether Elp3 plays any role in its maintenance. Lgr5+/
Dclk1+/Sox9+ cells were indeed identified by IF in ex vivo 
organoids from ApcΔCBC mice (Fig. 7 B). To address the role of 
Elp3 in their maintenance, we sorted EGFP-Lgr5+ cells from 
single-cell suspension of digested organoids generated from 
ApcΔCBC or ApcΔCBC Elp3ΔCBC mice by FACS analysis (un-
published data). Although Lgr5+ cell number did not change 
upon Elp3 deficiency, the amount of Dclk1+/Sox9+ cells in 
the Lgr5+ population strongly decreased upon Elp3 defi-
ciency in ex vivo organoids from ApcΔCBC mice (unpublished 
data and Fig.  7  C, respectively). Therefore, Elp3 promotes 
Wnt-driven tumor initiation, at least in part, by maintaining 
the pool of Lgr5+/Dclk1+/Sox9+ cells in the intestine.
Intestinal crypt regeneration upon irradiation requires Elp3
Because Wnt signaling critically promotes intestinal regener-
ation upon DNA damage (Ashton et al., 2010), and because 
Dclk1 expression has been shown to be required for survival 
after radiation injury (May et al., 2014), we next explored 
whether Elp3 deficiency had any consequence on radia-
tion-induced intestinal regeneration. Elp3Control or Elp3ΔIEC 
mice were subjected to 14Gy irradiation and cell prolifera-
tion was assessed in intestinal crypts. The number of regen-
erating crypts dramatically decreased upon Elp3 deficiency, 
as assessed by Ki67 staining performed 3 d after irradiation 
(Fig. 8 A). Sox9 protein, but not mRNA, levels severely de-
creased upon Elp3 deficiency in regenerating crypts from 
irradiated mice (Fig. 8 B). Importantly, mRNA and protein 
levels of Dclk1 were also dramatically impaired in IECs of 
irradiated Elp3-deficient mice (Fig. 8 C). To further explore 
whether Elp3 promotes radiation-induced intestinal regener-
ation through Sox9 expression, we expressed the Elp3 insensi-
tive Sox9ΔAAA mutant into control or Elp3-deficient RKO 
cells and assessed cell proliferation post-irradiation (Fig. 8 D). 
Importantly, Elp3-deficient RKO cells in which Sox9 expres-
sion was expectedly defective failed to efficiently proliferate 
post-irradiation. On the other hand, Elp3-deficient RKO 
cells in which the Sox9ΔAAA mutant was ectopically ex-
values ± SD; Student’s t test; ***, P < 0.001). (I) Representative pictures of ex vivo organoid cultures using intestinal crypts from 120-d-old Apc+/min Elp3Control 
and Apc+/min Elp3ΔIEC mice are shown (left). Quantification of the total number of spheroid structures per well for each genotype is illustrated (mean values 
± SD; Student’s t test; ***, P < 0.001). Red and black arrows depict cells that will give rise to spheroid structures or not, respectively.
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pressed proliferated similarly to control RKO cells and showed 
normalized levels of Dclk1 (Fig. 8 D). Collectively, our data 
demonstrate that Elp3 mediates regeneration after irradiation 
by maintaining Sox9 expression.
DIS CUSSI ON
We defined here Elp3 as a target of Wnt signaling dispensable for 
intestinal homeostasis but essential for Tuft cell differentiation, 
Wnt-driven tumor initiation, and radiation-induced regenera-
tion in the intestine. Although nuclear levels of β-catenin and 
constitutive Wnt-dependent gene transcription do not require 
Elp3 in the intestine, our data demonstrate that the translation 
of Sox9, a protein induced by Wnt, is controlled by Elp3 to 
maintain a pool of Lgr5+/Dclk1+/Sox9+ cancer stem cells.
Tuft cells derive from Lgr5+ crypt columnar stem cells 
but their differentiation and biological roles remain poorly 
Figure 4. Elp3 deficiency in Lgr5+ cells impairs 
Wnt-driven tumor initiation. (A) ApcΔCBC and 
ApcΔCBC Elp3ΔCBC mice were intraperitoneally injected 
with tamoxifen and intestinal crypts, isolated 15 
d later, and then subjected to H&E, anti-Ki67, and 
anti-Dclk1 IHCs, as indicated. Arrows highlight hy-
perplasias. (B) Quantification of the number of hy-
perplasias/1,000 µm in each genotype is illustrated 
(mean values ± SD; Student’s t test; ***, P < 0.001; n 
= 4). (C) The number of Dclk1+ cells per 100 cells in 
healthy areas and in hyperplasias was quantified for 
both genotypes (mean values ± SD; Student’s t test; 
*, P < 0.05; ***, P < 0.001; n = 10; right). Representa-
tive Dclk1 and Ki67 IHC analyses from the indicated 
genotypes are illustrated (left). (D) Representative 
pictures of ex vivo organoid cultures using intesti-
nal crypts from ApcΔCBC and ApcΔCBC Elp3ΔCBC mice 
are shown. Quantification of the number of spheroid 
structures per field (mean values ± SD; Student’s t 
test; ***, P < 0.001). (E) Lgr5+ cells FACS-sorted from 
ApcΔCBC or ApcΔCBC Elp3ΔCBC mice (n = 4), 15 d after 
tamoxifen administration were serial diluted to gen-
erate ex vivo spheroid structures (n = 4). 7 d after 
seeding, the number of wells containing spheroid 
structures was quantified. The cancer stem cell (CSC) 
potential was calculated for both genotypes, using 
the ELDA software (see Materials and methods for 
details; Chisq = χ2 test). (right) Graph showing the 
percentage of positive wells per genotype normal-
ized on 1,000-cell dilution conditions (mean values 
± SD; Student’s t test; *, P < 0.05; **, P < 0.01). (left) A 
summary table of organoid-positive wells (absolute 
numbers) in all experimental conditions is shown 
with representative images of spheroid structures.
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understood (Gerbe et al., 2011; Bjerknes et al., 2012). We 
found here that Elp3 is critical for Tuft cell differentiation, as 
its absence leads to dramatic reduction of Dclk1+ Tuft cells 
in the intestinal epithelium. The reduction of differentiated 
Tuft cells in Elp3-deficient mice did not lead to any detect-
able functional defect or to significant change in intestinal ar-
chitecture, indicating that Tuft cells are dispensable for global 
intestinal homeostasis. Mechanistically, it is unclear how Elp3 
promotes Tuft cell differentiation. Levels of the Atoh1/Math1 
transcription factor, which appear to be critical for secretory 
cell lineage commitment and for Tuft cell differentiation, are 
normally expressed in Elp3-deficient intestinal crypts (Shroyer 
et al., 2007; Gerbe et al., 2011). Therefore, Elp3 expression 
may control a late step of the epithelial cell lineage commit-
ment. A gene network between Atoh1, Hes1, and Gfi1B was 
previously demonstrated to be critical for epithelial lineage 
commitment in the intestine (Bjerknes et al., 2012). High 
concentrations of Gfi1B in daughter cells of short-lived pro-
genitors commit them to Tuft cell differentiation. Our data 
support this model, as Gfi1B mRNA levels are severely 
Figure 5. Elp3 deficiency in intestinal 
epithelial cells of Apc+/min mice impairs 
Dclk1 expression. (A and B) Tumors were 
isolated from 120-d-old Apc+/min Elp3Control 
and Apc+/min Elp3ΔIEC mice and the resulting 
total mRNAs were subjected to quantitative 
real-time PCR analysis to assess mRNA levels 
of the indicated candidates. Tumors efficiently 
recombined for Elp3 were selected. The mean 
value of mRNA levels in Apc+/min Elp3Control of 
each candidate was set to 100% and Apc+/min 
Elp3ΔIEC were expressed relative to that after 
normalization with GAP DH (mean values ± 
SD; Student’s t test; *, P < 0.05; n ≥ 4). (C) 
Dclk1 protein expression was assessed by IHC 
in intestinal cystic lesions and adenomas of 
120-d-old Apc+/min mice. (D) Anti-Dclk1 IHC 
analyses were conducted with intestinal crypts 
of 120-d-old Apc+/min Elp3Control and Apc+/min 
Elp3ΔIEC mice. The number of Dclk1+ cells per 
intestinal crypt was quantified in each indi-
cated genotype (mean values ± SD; Student’s 
t test; **, P < 0.01; n = 5). (E) Protein extracts 
from IECs of 120-d-old mice of the indicated 
genotypes were subjected to anti-Dclk1 and 
α-tubulin (loading control) WB analysis. (F) 
The number of Dclk1+ cells per 100 cells was 
quantified in the intestine from the indicated 
genotypes (mean values ± SD; Student’s t test; 
*, P < 0.05; ***, P < 0.001; n ≥ 4). (G) Anti-Dclk1 
and acetylated α-tubulin IF analyses were 
performed to distinguish and quantify Tuft 
cells versus Dclk1+ cancer stem cells in Apc+/
min Elp3Control and Apc+/min Elp3ΔIEC mice (mean 
values ± SD; Student’s t test; *, P < 0.05; **, 
P < 0.01; ***, P < 0.001; n ≥ 10 tumors). (H) 
ApcΔCBC organoids were infected with the in-
dicated shRNA construct and their growth was 
assessed. Western blot analyses carried out 
with extracts from the resulting organoids are 
illustrated.The number of organoids per well 
was quantified. The histogram shows the data 
from three different mice (mean values ± SD; 
Student’s t test; **, P < 0.01).
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Figure 6. Elp3 drives Sox9 expression. (A; left) Anti-Sox9 IHC analyses were conducted with intestinal crypts of 120-d-old mice of the indicated geno-
types. (right) The number of Sox9+ cells per intestinal crypt was quantified in each genotype (mean values ± SD; Student’s t test; *, P < 0.05; ***, P < 0.001; n 
≥ 4). (B) Protein extracts from IECs of 120-d-old mice of the indicated genotypes were subjected to anti-Sox9 and -Hsp90 (loading control) WB analyses. (C) 
IECs were isolated from 120-d-old mice of the indicated genotypes and the resulting total mRNAs were subjected to quantitative real-time PCR analysis to 
assess Sox9 and Igfbp4 mRNA levels (mean values ± SD; Student’s t test; **, P < 0.01; n = 5). (D) RKO cells were untreated or stimulated with Wnt 3a for the 
indicated periods of time and the resulting cell extracts were subjected to WB analyses using the indicated antibodies. (E) ApcΔCBC organoids were infected 
with the indicated shRNA construct and their growth was assessed. (right) the number of organoids per well was quantified. The histogram shows the data 
from three different mice (mean values ± SD; Student’s t test; *, P < 0.05; **, P < 0.01). (F) Total protein extracts from fission yeast cells of the indicated 
genotypes expressing Sox9 and containing either a plasmid overexpressing the tRNAlysUUU (K) or the corresponding empty vector (/) were subjected to an-
ti-Sox9 and anti–α-tubulin (loading control) WB analyses. (G) A construct generating wild-type Sox9 or a Sox9 mutant in which all lysine residues (K) were 
mutated into arginines (R; Sox9ΔAAA) was expressed in yeast cells of the indicated genotypes and the resulting cell extracts were subjected to WB analyses.
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decreased in Elp3-deficient intestinal crypts. Therefore, Elp3 
may promote Tuft cell differentiation through Gfi1B.
Cell migration of multiple primary and transformed cells 
requires Elongator (Close et al., 2006; Johansen et al., 2008; 
Creppe et al., 2009; Lee et al., 2009). Cell invasion of glioblas-
toma-, neuroblastoma-, and melanoma-derived cells also relies 
on Elp3 (Close et al., 2006, 2012). Further, our results show 
that colonosphere formation from colon cancer–derived cells 
was greatly dependent on Elp3. It remains to be seen whether 
the inactivation of Elp3 in ex vivo organoid cultures generated 
from human cases of intestinal cancer also interferes with their 
growth. We also show here that Elp3 is essential in initial steps of 
tumor development in vivo using a mouse model of intestinal 
Wnt-dependent tumor initiation. Our data demonstrate that 
Elp3 expression increased upon constitutive Wnt activation. 
Therefore, we highlight a positive correlation between Elp3 
expression and the activation of a major oncogenic pathway. 
This suggests that Elp3 may also be critically involved in the 
development of other epithelial malignancies harboring dereg-
ulated Wnt signaling (Michaelson and Leder, 2001; Ayyanan et 
al., 2006). Future studies will be dedicated to the identification 
of all oncogenic pathways that regulate Elp3 expression.
Dclk1+ cells are differentiated Tuft cells in normal in-
testinal epithelium but they were also defined as cancer stem 
cells upon Apc loss (Nakanishi et al., 2013). A subpopula-
tion of long-lived and quiescent Dclk1+ cells acting as tu-
mor-initiating cells was also identified (Westphalen et al., 
2014). Surprisingly, loss of Apc in these Dclk1+ cells did not 
cause nuclear translocation of β-catenin and, consequently, 
did not trigger adenoma formation. These quiescent Dclk1+ 
cells could nevertheless be reactivated and act as tumor-initi-
ating cells only when Apc loss was combined with an inflam-
matory stimulus such as dextran sodium sulfate (DSS) colitis 
(Westphalen et al., 2014). We show that Elp3 deficiency in 
Apc-mutated Lgr5+ intestinal stem cells blocks tumor initia-
tion by limiting the number of Lgr5+/Dclk1+/Sox9+ cancer 
stem cells. Because a bidirectional conversion between tumor 
initiating and differentiated cells that relies on inflammatory 
signals has been established (Schwitalla et al., 2013), it remains 
to be tested whether fully differentiated Dclk1+ Tuft cells can 
undergo dedifferentiation to convert into so-called Dclk1+ 
tumor initiating cells.
Our data defined Elp3 as a critical protein for Sox9 
translation in both normal and Apc-mutated intestinal crypts. 
Figure 7. Elp3 expression is required to 
maintain a pool of Lgr5+/Dclk1+/Sox9+ 
cells upon constitutive Wnt signaling. (A) 
ApcΔCBC organoids were infected with a pool 
of lentiviral constructs delivering shRNA tar-
geting Sox9, Elp3 or an irrelevant sequence 
used as negative control (shRNA Sox9, shRNA 
Elp3 and shRNA Ctrl, respectively). (top) Pro-
tein extracts from resulting ApcΔCBC organoids 
were subjected to anti-Dclk1, -Sox9, -Elp3 and 
β-Actin (loading control) WB analyses. (bot-
tom) Total mRNAs from those organoids were 
subjected to quantitative real-time PCR anal-
ysis to monitor expression levels of the indi-
cated transcripts. The abundance of transcripts 
in shRNA Ctrl condition was set to 100% and 
levels of the other transcripts were expressed 
relative to that after normalization to GAP DH. 
Data with organoids derived from three differ-
ent mice are shown (mean values ± SD; Stu-
dent’s t test; **, P < 0.01). (B) Anti-Dclk1 (gray), 
anti-Sox9 (red), and anti-EGFP (green) IF anal-
yses were carried out to visualize the Lgr5+/
Sox9+/Dclk1+ cell population in ApcΔCBC organ-
oids. (C) Single-cell suspensions of digested 
organoids from ApcΔCBC or ApcΔCBC Elp3ΔCBC 
mice were stained for Sox9 and Dclk1 and 
were subjected to FACS analysis. Lgr5-EGFP+ 
cells were selected. (left) A representative Dot 
plot of Lgr5-EGFP+ cells stained for Sox9 and 
Dclk1 is illustrated. 10,000 events per mice 
were analyzed. (right) The histogram shows a 
quantification of the Dclk1+/Sox9+ cells in the 
Lgr5+ population (n ≥ 3 for each genotype; 
mean values ± SD; Student’s t test; **, P < 0.01).
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Sox9 is expressed in several differentiated epithelial lineages, 
such as Tuft and Paneth cells. Moreover, two distinct Sox9-ex-
pressing stem cell populations were also defined using EG-
FP-expressing transgenic mice, namely Sox9-EGFPlow and 
Sox9-EGFPhigh populations (Van Landeghem et al., 2012). 
Sox9-EGFPlow cells are Lgr5-enriched stem cells, whereas 
Sox9-EGFPhigh cells express enteroendocrine and +4 stem 
cell markers. The decreased Sox9 expression seen upon Elp3 
deficiency does not result from a lower number of Paneth 
cells, as they appear to be functional, at least based on intact 
lysozyme levels seen in Elp3-deficient intestinal crypts. Sim-
ilarly, the enteroendocrine and +4 stem cells populations are 
also intact upon Elp3 deficiency. A study concluded that Sox9 
is dispensable for Tuft cell differentiation (Gerbe et al., 2011). 
Whether Elp3 promotes Tuft cell differentiation through 
Sox9 regulation remains unclear, and it is likely that other 
candidates whose Wnt-dependent protein translation relies 
on Elp3 contribute to Tuft cell differentiation.
The role of Sox9 in Wnt-driven tumor development in 
vivo remains controversial. Indeed, Sox9 inactivation appears 
Figure 8. Elp3 promotes radiation-induced intes-
tinal regeneration. (A; left) Representative pictures 
of Ki67 and H&E staining of intestinal crypts from 
Elp3Control and Elp3ΔIEC mice 3 d after 14 Gy irradiation. 
(right) The number of regenerating crypts according 
to Ki67+ cells per mm was quantified for the indicated 
genotypes (mean values ± SD; Student’s t test; ***, P 
< 0.001; n = 5). (B) Protein and mRNA extracts from 
IECs from Elp3Control and Elp3ΔIEC mice 3 d after irradi-
ation were subjected to anti-Sox9 and Hsp90 (loading 
control) WB or to quantitative real-time PCR analyses 
(n = 4). (C) Protein and mRNA extracts from jejunal 
epithelial cells from Elp3Control and Elp3ΔIEC mice 3 d 
after irradiation were subjected to anti-Dclk1 and 
α-tubulin (loading control) WB or to quantitative Real 
time PCR analyses (mean values ± SD; Student’s t test; 
***, P < 0.001; n = 4). (D) Control or Elp3-depleted RKO 
cells were transfected with an empty vector or with 
the Sox9ΔAAA mutant, as indicated and were subse-
quently untreated or irradiated with 3 Gy/min (Day 
0). (left) Cell extracts were subjected to WB analyses 
using the indicated antibodies. Cells showing DNA 
damage are positive for pH2AX. (right) Cell prolifer-
ation in all experimental conditions was measured by 
Crystal Violet at the indicated time points. The mean 
of two independent experiments performed in dupli-
cate is illustrated (mean values ± SD; Student’s t test; 
**, P < 0.01). At the bottom, representative images of 
cells stained with Crystal Violet are shown.
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to increase tumor burden in the Apc+/min model, which ap-
pears to be consistent with the fact that Sox9 acts as a Wnt 
inhibitor (Akiyama et al., 2004; Shi et al., 2013). On the other 
hand, Insulin Receptor Substrate-1 (IRS-1) deficiency also 
limited tumor development in Apc+/min mice, at least because 
of impaired Sox9 expression (Ramocki et al., 2008). These 
data, combined with our study, rather support the hypothesis 
that a defective Sox9 expression in cancer stem cells impairs 
Wnt-driven cancer development and intestinal regeneration. 
Indeed, our results show that Sox9 deficiency also impacts 
on the growth of Apc-mutated ex vivo organoids. Our data 
are actually in agreement with the recently demonstrated key 
role of Sox9 in promoting the self-renewal of oncogene-ex-
pressing cells downstream of Wnt signaling in a genetic model 
of basal cell carcinoma (Larsimont et al., 2015). This study, 
combined with our current work, may reveal a role of Elp3 
in any cancer model in which Sox9 critically maintains the 
self-renewal capacity of cancer stem cells.
Elp3 promotes Sox9 translation through tRNA modi-
fication in fission yeast. A study in this model suggested that 
proteins whose translation requires Elp3 show enriched rep-
resentation of AAA codons (Bauer et al., 2012). Surprisingly, 
Sox9 coding sequence is not enriched in AAA codons, yet 
tRNAlysUUU efficiently restored Sox9 expression in elp3-de-
leted yeast, and a Sox9 mutant in which all 3 AAA codons 
were mutated is still properly translated in elp3-deficient 
yeast cells. Therefore, our data further strengthen the no-
tion that AAA codons rely on properly modified tRNAs to 
be efficiently translated and also define Sox9 as a Wnt-in-
duced protein whose expression is critically controlled 
at the translation level.
The identity of intestinal cells required for radiation-in-
duced intestinal regeneration has been the subject of multiple 
studies. These cells are Sox9+ and reexpress Lgr5 to undergo 
proliferation in regenerating intestinal crypts (Van Landeghem 
et al., 2012; Metcalfe et al., 2013). Consistently, Sox9 expres-
sion is required to maintain reserve stem cells to promote 
regeneration upon radiation (Roche et al., 2015). We show 
that Elp3 is required in radiation-induced regeneration in the 
intestine, at least by promoting Sox9 expression at the protein 
level. ELP3-deficient cells in which a Sox9 mutant whose 
translation is ELP3-independent is ectopically expressed effi-
ciently proliferate after irradiation. Dclk1 expression was also 
severely decreased upon Elp3 deficiency in the regenerating 
intestinal crypts. Although a study had shown that Dclk1 in-
activation did not impair the number of surviving crypts, but 
decreased survival of irradiated mice as a result of disrupted 
tight junctions (May et al., 2014), another study highlighted 
a critical role for a subpopulation of Dclk1+ cells in radia-
tion-induced intestinal regeneration (Westphalen et al., 2014). 
Our results suggest that intestinal regeneration upon radia-
tion may rely on a specific Lgr5+/Dclk1+/Sox9+ pool of cells 
whose maintenance critically relies on Elp3. Our study de-
fines a key role for Elp3 in the DNA damage response in the 
intestine. An increased sensitivity of Elp3 mutants to DNA 
damage was previously reported in yeast, which demonstrates 
that Elp3 critically controls the DNA damage response in 
multiple organisms (Li et al., 2009; Chen et al., 2011).
The molecular mechanisms underlying Elp3 functions 
remain poorly understood. It is currently believed that Elp3 
promotes the acetylation of multiple substrates in distinct cell 
compartments to regulate transcriptional elongation in the 
nucleus and protein translation in the cytoplasm. Such hy-
pothesis was recently experimentally validated while address-
ing the role of Elp3 in meiosis during spermatogenesis (Lin 
et al., 2013). We showed here that Elp3 acts downstream of 
Wnt, and as such, may contribute to Wnt-dependent protein 
acetylation, transcriptional elongation and/or to Wnt-de-
pendent protein translation through tRNA modifications to 
promote tumor initiation and intestinal regeneration. Because 
Elp3 has been recently defined as a tRNA acetyltransferase 
(Selvadurai et al., 2014), our future studies will be dedicated 
to the elucidation of the Wnt- and Elp3-dependent protein 
signature involved in tumor development.
Elp3 deficiency in Apc-mutated intestinal crypts shares 
many features with the genetic inactivation of Myc in those 
crypts (Sansom et al., 2007). Whereas our data disclose a role 
of Elp3 in the transcription of Myc, both Elp3 and Myc may 
control the same pool of cancer stem cells to drive tumor 
development in the intestine. Interestingly, the genetic inacti-
vation of Raptor, an essential component of mTORC1, also 
interferes with Wnt-dependent tumor growth but not with 
normal gut homeostasis (Faller et al., 2014). mTORC1 is re-
quired for cell proliferation in Apc-mutated intestinal crypts 
through S6K activation by increasing the rate of translational 
elongation of yet to be defined polypeptides. Therefore, 
it is tempting to speculate that Elp3 may act in this path-
way by promoting protein translation of those polypeptides 
through tRNA modifications.
As cancer stem cells critically rely on Elp3 to promote 
Wnt-dependent cancer development, and given the fact that 
Elp3 deficiency in normal intestine did not interfere with 
intestinal homeostasis, targeting Elp3 activity may represent a 
promising therapeutic approach to treat colon cancer. Future 
studies in human samples of intestinal cancers will be per-
formed to generalize our conclusions and to validate the hy-
pothesis that Elp3 is a suitable target to treat intestinal cancers 
showing constitutive Wnt signaling.
MAT ERIALS AND MET HODS
Cell lines and reagents. HT29 and RKO cells were cultured 
in McCoy’s 5A medium supplemented with 10% FBS, 1% 
glutamine, and 1% penicillin/streptomycin. HEK 293 Lentix 
cells were cultured in DMEM medium supplemented with 
10% FBS, 1% glutamine, and 1% penicillin/streptomycin.
Anti–β-catenin, -Elp1, and -Hsp90 antibodies used in 
Western blot analyses were obtained from Santa Cruz Bio-
technology, Inc. The anti-Elp3 antibody was provided by Cell 
Signaling Technology. Anti–α-tubulin and –acetyl-α-tubulin 
antibodies were purchased from Sigma-Aldrich. Anti-Histone 
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H3, -pH2AX, and -Dclk1 antibodies were obtained from 
Abcam, and anti-Sox9 and Ephrin B2 antibodies were pur-
chased from EMD Millipore and R&D Systems, respectively.
Generating the conditional Elp3 KO mouse. The Elp3 gene 
(Ensembl gene ID, mouse ENS MUSG00000022031) is lo-
cated on chromosome 14. Elp3 exon 1 harbors the translation 
initiation codon. The targeting strategy was designed to gen-
erate the conditional KO (cKO), as well as the constitutive 
KO alleles of the Elp3 gene (Taconic; Fig. 2 A). The targeting 
vector was generated using BAC clones from the C57BL/6J 
RPC IB-731 BAC library (clones RP23-233H18, RP23-
220M13, RP23-236C3, RP23-435F17, and RP23-450B15) 
and transfected into the C57BL/6N Tac ES cell line (Taconic). 
Exon 2 was flanked by loxP sites, and the positive selection 
marker was flanked by F3 (Puromycin resistance [PuroR]) 
sites and inserted into intron 1. Homologous recombinant 
clones were isolated using positive (PuroR) selection. Mutant 
Elp3 mice were generated by Taconic. In brief, E3.5 blasto-
cysts from superovulated BALB/cbfemales were injected with 
targeted C57BL/6 N.tac ES cells and transferred to pseudo-
pregnant NMR1 females. Chimerism was determined ac-
cording to the black/white coat color which reflects the 
contribution of ES cells to the BALB/c host. Highly chime-
ric mice were bred to C57BL/6 females and germline trans-
mission was identified by C57BL/6 (black) in offspring was 
performed by Southern blot analysis. Crossbreeding of chi-
meric mice with Flp Deleter mice for in vivo selection marker 
deletion was performed to generate mice heterozygous for 
the conditional KO allele. The constitutive KO allele was ob-
tained after Cre-mediated recombination. Deletion of exon 2 
results in the loss of function of Elp3 by generating a frame-
shift to all downstream exons. For genotyping analysis, the 
floxed allele, defined as the conditional allele, was identified 
by PCR conducted on DNAs extracted from tails (Fig. 2 A). 
Primer sequences are available upon request. To inactivate 
Elp3 in the intestine (Elp3ΔIEC), the Elp3loxp/loxp mouse was 
crossed with the VillinCre/+ strain. PCR analysis using primers 
1 and 2 were conducted on DNAs extracted from tissues of 
control or Elp3ΔIEC mice to amplify 1,341- and 172-bp prod-
ucts from the conditional versus the constitutive knockout 
allele, respectively (Fig. 2, A and B).
Transgenic mouse models, tamoxifen injections, and expo-
sures to radiation. The Apc+/min strain (C57BL/6J-ApcMin/J), 
as well as the Lgr5-EGFP-IRES-creERT2 (B6.129P2-Lgr5t-
m1(cre/ESR1)Cle/J) heterozygote knock-in mouse were purchased 
from The Jackson Laboratory, whereas the VillinCre/+ strain 
was purchased from Genoway. The Apclox/lox strain was pre-
viously described (Sansom et al., 2007). All mice were in the 
C57BL/6 background, excepted for Apclox/lox mice that were 
three parts C57BL6 and one part Sv129. All experiments 
were approved by the local ethical committee (University of 
Liège, Liège, Belgium). For conditional inactivation of Elp3 
in Lgr5+ cells, four daily injections of 2 mg tamoxifen in 
sunflower oil were performed intraperitoneally to the stem 
cell–specific Lgr5-EGFP-IRES-creERT2 knock-in mice as 
control (Lgr5-EGFP-Elp3Control) or to mice resulting from the 
breeding between Lgr5-EGFP-IRES-creERT2 mice and the 
Elp3Control strain to generate the Lgr5-EGFP-Elp3ΔCBCstrain. 
For the simultaneous inactivation of Elp3 and Apc in Lgr5+ 
cells, four daily injections of 2 mg tamoxifen in sunflower oil 
were performed intraperitoneally to mice resulting from the 
cross of Apclox/lox mice with the Lgr5-EGFP-IRES-creERT2 
strain (ApcΔCBC) as control or to mice resulting from the 
cross of Apclox/lox mice with the Lgr5-EGFP-IRES-creERT2 
and the Elp3Control strain (ApcΔCBC Elp3ΔCBC). The sequence 
of all primers used for genotyping purposes are available 
upon request. To assess radiation-induced intestinal regen-
eration, 8 –10-wk-old mice were exposed to 14Gy from a 
137Cs source, as previously described (Ashton et al., 2010). 
Mice were given buprenorphine twice a day and were sacri-
ficed 72 h after radiation.
Intestinal epithelial cells extraction and ex vivo organoid 
cultures. Intestines and colons were extracted from mice and 
cecum was removed. Intestine was divided into three parts of 
the same size and defined as the proximal, middle, and distal 
intestine. Bowels were subsequently cut in half longitudinally. 
Half of the tissue was rolled and used for histological purposes 
and the other half was used for intestinal epithelial cells ex-
traction. In brief, bowels were washed for 10 min at 37°C in 
a PBS-DTT (1 mM) buffer, and then incubated for 15 min at 
37°C in a HBSS-EDTA buffer (30  mM). Cells were har-
vested, washed twice in PBS, and flash frozen.
Ex vivo organoid cultures were performed as previously 
described (Sato et al., 2009). In brief, small pieces of intes-
tine were incubated in 2 mM EDTA-PBS for 30 min at 4°C. 
Crypts were extracted, washed twice in PBS and cultured at 
same density in Matrigel (BD). DMEM/F12 supplemented 
with EGF (20 ng/ml), Noggin (100 ng/ml), and R-Spon-
din (500 ng/ml) was added every 2 d. Apc-mutated organ-
oids were cultured in DMEM/F12 supplemented with EGF 
(20 ng/ml) and Noggin (100 ng/ml) without R-Spondin. 
For the generation of organoids from ApcΔCBC and ApcΔCBC 
Elp3ΔCBC mice, animals were treated with tamoxifen.
Limiting dilution assay. Crypts from ApcΔCBC and ApcΔCBC 
Elp3ΔCBC mice treated with tamoxifen were extracted as de-
scribed above. To generate a unicellular suspension of the ex-
tracted crypts, we digested them for 30 min at 37°C with 10× 
Trypsin and centrifuged them at 150 rcf for 5 min. The pellet 
was resuspended in 1%BSA/1× PBS and filtered in a 70-µm 
cell strainer to be centrifuged at 150 rcf for 5 min. Finally, the 
pellet was resuspended in 1  ml 1%BSA/1× PBS and EG-
FP-Lgr5+ cells were sorted using the FAC SAria (BD). EG-
FP-Lgr5+ sorted cells were counted and seeded in Matrigel as 
indicated in the figure. DMEM/F12 supplemented with EGF 
(20 ng/ml) and Noggin (100 ng/ml) was added every 2 d. 
Wells positive for organoid growth were quantified after 7 d. 
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Statistical analysis was performed by as previously de-
scribed (Hu and Smyth, 2009).
Flow cytometry. Crypts were extracted after 30 min of incu-
bation in 2 mM EDTA-PBS at 4°C, and then digested into 
single cells using the trypLE express solution (Life Technolo-
gies) containing 200 U of DNase for 30 min at 37°C. Cells 
were washed in 1% BSA/PBS. Resuspended cells were sorted 
on the BD FAC SAria. For phenotyping, organoids were col-
lected, washed in PBS, and digested for 20 min using the 
trypLE express solution. The resulting single-cell solution was 
fixed with 4% paraformaldehyde solution, permeabilized 
with Perm-Wash solution (BD), and stained with anti-Sox9 
and -Dclk1 antibodies (Abcam) for 30 min at 4°C. Corre-
sponding secondary antibodies (Life Technologies) were in-
cubated for 30 min at 4°C. The FlowJo software 
was used to analyze data.
Total RNA extraction and real-time PCR. Total RNA from 
cell lines was extracted using the total RNA kit (Omega 
Biotek) according to manufacturer’s instructions. For mice 
samples, total RNA was extracted using the TriPure Isolation 
Reagent (Roche). All samples were subsequently treated with 
the Recombinant DNase (Roche). cDNAs were synthesized 
using the Revert Aid H Minus First Strand cDNA Synthesis 
kit (Fermentas). Subsequent PCRs were performed using the 
Power SYBR Green PCR Master kit (Takara Bio Inc.) on 
the LightCycler 480 (Roche). The mean value of mRNA 
levels in control mice was set to 100% and levels in mutant 
mice were expressed relative to that after normalization with 
glyceraldehyde-3-phosphate dehydrogenase GAP DH. Data 
are plotted as mean values ± SD. All primer sequences used 
are available upon request.
Lentiviral infections. The control or shRNAs targeting Dclk1, 
ELP3, β-catenin, or Sox9 were purchased from Sigma-Aldrich. 
Lentiviral infections in RKO orHT29 cells were performed 
as previously described (Creppe et al., 2009). Lentiviral infec-
tions in ex vivo organoids were performed as previously de-
scribed (Koo et al., 2012).
Chromatin immunoprecipitation assays. Cells were fixed in 
formaldehyde 1% for 10 min at room temperature, quenched 
in 1.25 M glycine and lysed in SDS 1% lysis buffer. Lysates 
were sonicated 15 min using the Bioruptor (Diagenode), 
cleared by centrifugation and used for immunoprecipitation. 
Extracts were precleared by 1 h incubation with protein G/
Herring sperm DNA/BSA, and immunoprecipitation was 
performed by incubating overnight at 4°C with the an-
ti-TCF4 antibody, using IgG antibody as negative control, 
and then 1  h with protein G/Herring sperm DNA/BSA. 
Protein–DNA complexes were washed as per standard ChIP 
techniques. After elution, proteinase K treatment, and reversal 
of cross-links, DNA fragments were analyzed by quantitative 
real-time PCR using SYBr Green for detection. Input DNA 
was analyzed simultaneously and used as normalization. 
Primers used are available upon request.
Immunofluorescence and immunohistochemistry analyses. 
For immunohistochemistry analyses, samples were fixed over-
night in 4% formalin solution and embedded in paraffin. In 
brief, 3-µm-thick sections of FFPE tumors were deparaffin-
ized and antigen retrieval was performed by boiling the sec-
tions in citrate buffer at pH 6.0 or EDTA at pH 9.0 for 20 
min. Primary antibodies used were as follows: Dclk1 (1:50; 
pH 6.0; Abcam), Sox9 (1:50; pH 6.0; Millipore), Ki67 (1:50; 
pH 6.0; Cell Marque), corresponding secondary antibody de-
tection kits for reduced background on murine tissue were 
used (Histofine Simple Stain Mouse MAX PO; Medac) and 
stained on an automated stainer (LabVision Autostainer 480S; 
Thermo Fisher Scientific). All slides were scanned with a 
Panoramic 250 slide scanner (3D Histech.com).
For immunofluorescence, frozen sections were in-
cubated in the target retrieval solution (Dako) for 7 min. 
Primary antibodies are listed in the Cell lines and re-
agents section. Slides were analyzed using a sp5 con-
focal microscope (Leica).
Expression of Sox9 in fission yeast and tRNA overexpres-
sion. The pLVX-Sox9-EGFP expression construct, a gift 
from S.T. Magness (University of North Carolina at Chapel 
Hill, Chapel Hill, NC), was used as template to generate the 
Sox9ΔAAA mutant by site-directed mutagenesis, using the 
protocol provided by the manufacturer (Agilent Technolo-
gies). Wild-type Sox9 and the Sox9ΔAAA cDNA mutant 
were amplified by PCR and cloned in the fission yeast ura4-
based pREP4 that allows expression from the nmt1 pro-
moter, which is repressed by thiamine. Wild-type and 
elp3-deleted strains were transformed with the pREP4-
Sox9 plasmid and selected in EMM medium in the absence 
of uracil. The tRNAlysUUU cloned in a leu2-based vector 
as previously described (Bauer et al., 2012), or an empty 
vector, were also transformed and co-selected with the 
pREP4-sox9 on medium lacking both leucine and uracil. 
The expression of Sox9 was induced by growing cells for 
22 h in the absence of thiamine. Cells were harvested at OD 
0.5 (10 ml) and lysed in the presence of zirconium beads, as 
previously described (Fersht et al., 2007). Total protein ex-
tracts were subjected to anti-Sox9 and α-tubulin (loading 
control) Western blot analyses.
Statistical analysis. Student’s t test was performed to test sta-
tistical relevance, unless otherwise specified. For quantifica-
tion of Elp3 immunohistochemistry of human biopsies, total 
H-DAB positive areas of each slide were calculated using the 
ImageJ software. Specifically, H-DAB positivity was quanti-
fied from the transformed images by ImageJ IHC Toolbox. 
Measurements were calculated in pixels, and the analysis was 
done blindly. Data are expressed as percentage of H-DAB–
positive pixels on total pixels per slide.
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